Table 1 Laboratory test results on admission
Test | Result | Reference Renge (Unit) | |
|---|---|---|---|
Complete blood count | Neutrophils | 2630 | 3500–9700 (/μL) |
Lymphocytes | 12.0 | 18.0–50.0 (%) | |
Monocytes | 0.0 | 1.0–8.0 (%) | |
Eosinophils | 0.0 | 0.0–7.0 (%) | |
Basophils | 0.0 | 0.0–2.0 (%) | |
RBCs | 492 | 376–516 × 10^4 (/μL) | |
Hemoglobin | 12.8 | 11.2–15.2 (g/dL) | |
Hematocrit | 39.0 | 34.3–45.2 (%) | |
RBCs MCV | 79 | 80–101 (fL) | |
RBCs MCH | 26.0 | 26.4–34.3 (pg) | |
RBCs MCHC | 32.6 | 31.3–36.1 (%) | |
Platelets | 1.1 | 14.0–37.9 × 10^4 (/μL) | |
Coagulation | PT | 23.3 | 10.0–13.0 (sec) |
INR | 1.94 | 0.90–1.13 | |
Fibrinogen | 185 | 170–410 (mg/dL) | |
D-dimer | > 60 | < 1 (μg/mL) | |
TAT | > 120 | < 4.0 (ng/mL) | |
Lupus anticoagulant | 1.3 | < 1.3 (normalized ratio) | |
vWF activity | > 200 | 50–150 (%) | |
Thrombomodulin | > 32 | 1.8–3.9 (FU/ml) | |
Blood Chemistry | Urea | 8.9 | 2.7–7.0 (mg/dL) |
Creatinine | 1.81 | 0.46–0.82 (mg/dL) | |
Sodium | 137 | 135–145 (mEq/L) | |
Potassium | 4.2 | 3.5–5.0 (mEq/L) | |
Chloride | 101 | 98–108 (mEq/L) | |
Total protein | 5.6 | 6.5–8.2 (g/dL) | |
Albumin | 2.8 | 3.7–5.5 (g/dL) | |
Triglyceride | 357 | 50–149 (mg/dL) | |
Alkaline phosphatase | 878 | 104–338 (U/L) | |
Total bilirubin | 4.0 | 0.3–1.2 (mg/dL) | |
Direct bilirubin | 3 | < 0.4 (mg/dL) | |
AST | 1556 | 10–40 (U/L) | |
ALT | 543 | 5–45 (U/L) | |
LDH | 3679 | 120–245 (U/L) | |
CK | 8040 | 5–210 (U/L) | |
CK-MB | 184.2 | < 5.0 (ng/mL) | |
Ferritin | 3877 | 21.8–274.7 (ng/mL) | |
CRP | 41.79 | < 0.30 (mg/dL) | |
Cytokine or bioactive substance | IL-1β | 34.9 | < 0.928 (pg/mL) |
IL-2 | < 15.6 | < 15.6 (pg/mL) | |
soluble IL-2R | 3630 | 145–519 (U/mL) | |
IL-6 | 1510 | < 2.41 (pg/mL) | |
IL-10 | 20.0 | < 2.03 (pg/mL) | |
IL-12 | < 0.78 | < 3.15 (pg/mL) | |
TNFα | 251 | < 1.79 (pg/mL) | |
INFγ | 9260 | < 20.6 (pg/mL) | |
G-CSF | 753 | 10.5–57.5 (pg/mL) | |
ADAMTS-13 activity | 37.8 | 70.0–120.0 (%) | |
ADAMTS-13 inhibitor | < 0.5 | < 0.5 (BU/mL) |